LN0513339
98% , 1271930-15-4
| Pack Size | Price | Stock | Quantity |
| 5mg | RMB12480.00 | In Stock |
|
| 10mg | RMB20841.60 | In Stock |
|
| 25mg | RMB41558.40 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Boiling point: | 552.2±50.0 °C(Predicted) |
| Density | 1.203±0.06 g/cm3(Predicted) |
| pka | 8.40±0.50(Predicted) |
| InChIKey | BMWNEBVDXWCUKG-CRPMJUFNNA-N |
| SMILES | C(N([C@@H](C1=C2C(C=CC=C2)=CC=C1)C)CCCC1=CC=CC(C(F)(F)F)=C1)CCC1=CC=CC(C(F)(F)F)=C1 |&1:2,r| |
Description and Uses
Cinacalcet Impurity D is a potential byproduct or impurity in the synthesis of the drug. It is essential to study the properties and potential implications of Cinacalcet Impurity D for pharmaceutical research. Cinacalcet is a drug commonly used for the treatment of hyperparathyroidism in patients with chronic kidney disease.
N-[(3-Trifluoromethyl)phenyl)propyl] Cinacalcet (Cinacalcet USP Related Compound B) is an impurity of Cinacalcet Hydrochloride (C441800). Cinacalcet is used in clinical trial in secondary hyperparathyroidism.




![1-NaphthaleneMethanaMine, 7,8-dihydro-α-Methyl-N-[3-[3-(trifluoroMethyl)phenyl]propyl]-, hydrochloride (1:1), (αR)-](https://img.chemicalbook.com/CAS/20180808/GIF/1020414-33-8.gif)